• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 454784 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417017011 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417017011 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Investors look to Lighten Up on Shares of Inovio Biomedical, Shares Down 23.1% (INO)

Published on Thu, 03/07/2013 - 11:23
By Peter Chu

Inovio Biomedical (AMEX:INO) is one of today's worst performing penny stocks, down 23.1% to $0.53 on 3.5x average daily volume. Thus far today, Inovio Biomedical has traded 5.2 million shares, vs. average volume of 1.5 million shares per day. The stock has underperformed the Dow (-23.1% to the Dow's 0.3%) and underperformed the S&P 500 (-23.1% to the S&P's 0.1%) during today's trading.

Potential upside of 239.4% exists for Inovio Biomedical, based on a current level of $0.53 and analysts' average consensus price target of $1.80. Inovio Biomedical shares should first meet resistance at the 200-day moving average (MA) of $0.57 and find additional resistance at the 50-day MA of $0.66.

In the past 52 weeks, Inovio Biomedical share prices have been bracketed by a low of $0.38 and a high of $0.83 and are now at $0.53, 40% above that low price. The 200-day and 50-day moving averages have moved 0.55% higher and 1.54% higher over the past week, respectively.

Inovio Biomedical Corporation is focused on developing multiple DNA-based immunotherapies. The Company develops applications of electroporation using brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceutical.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Watch for Shares of Air Products & Chemi...

Shares of Air Products & Chemicals (NYSE:APD) opened today below their pivot of $145.56 ...

FMC (FMC) Breaks Through Support at $55....

Shares of FMC (NYSE:FMC) opened today below their pivot of $56.41 and have already reac ...

Watch for Shares of Health Care REIT (HC...

Shares of Health Care REIT (NYSE:HCN) have bullishly opened above the pivot of $72.53 t ...

Watch for Shares of Jabil Circuit (JBL) ...

Jabil Circuit (NYSE:JBL) has opened bullishly above the pivot of $20.92 today and has r ...

Consolidated Edison (ED) Approaches New ...

Consolidated Edison (NYSE:ED) has opened bullishly above the pivot of $61.77 today and ...

Watch for Shares of Sysco (SYY) to Appro...

Shares of Sysco (NYSE:SYY) have bullishly opened above the pivot of $39.49 today and ha ...

Akamai Technologies (AKAM) Crosses Pivot...

Shares of Akamai Technologies (NASDAQ:AKAM) have bullishly opened above the pivot of $6 ...

Watch for Shares of Kellogg (K) to Appro...

Shares of Kellogg (NYSE:K) opened today below their pivot of $65.21 and have already re ...